United States Mesenchymal Stem Cells Market Report & Forecast 2021-2027

Publisher Name :
Date: 21-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Mesenchymal Stem Cells Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Mesenchymal Stem Cells Market Segment Percentages, By Type, 2020 (%)

- Human MSC

- Mouse MSC

- Rat MSC

- Others

United States Mesenchymal Stem Cells Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Mesenchymal Stem Cells Market Segment Percentages, By Application, 2020 (%)

- Research Institute

- Hospital

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Mesenchymal Stem Cells revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Mesenchymal Stem Cells revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Lonza

- Thermo Fisher

- Bio-Techne

- ATCC

- MilliporeSigma

- PromoCell GmbH

- Genlantis

- Celprogen

- Cell Applications

- Cyagen Biosciences

- Axol Bioscience

United States Mesenchymal Stem Cells Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Mesenchymal Stem Cells Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Mesenchymal Stem Cells Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Mesenchymal Stem Cells Overall Market Size
2.1 United States Mesenchymal Stem Cells Market Size: 2021 VS 2027
2.2 United States Mesenchymal Stem Cells Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mesenchymal Stem Cells Players in United States Market
3.2 Top United States Mesenchymal Stem Cells Companies Ranked by Revenue
3.3 United States Mesenchymal Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Mesenchymal Stem Cells Companies in United States Market, by Revenue in 2020
3.5 Companies Mesenchymal Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mesenchymal Stem Cells Players in United States Market
3.6.1 List of Tier 1 Mesenchymal Stem Cells Companies in United States
3.6.2 List of Tier 2 and Tier 3 Mesenchymal Stem Cells Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Mesenchymal Stem Cells Market Size Markets, 2021 & 2027
4.1.2 Human MSC
4.1.3 Mouse MSC
4.1.4 Rat MSC
4.1.5 Others
4.2 By Type - United States Mesenchymal Stem Cells Revenue & Forecasts
4.2.1 By Type - United States Mesenchymal Stem Cells Revenue, 2016-2021
4.2.2 By Type - United States Mesenchymal Stem Cells Revenue, 2022-2027
4.2.3 By Type - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Mesenchymal Stem Cells Market Size, 2021 & 2027
5.1.2 Research Institute
5.1.3 Hospital
5.1.4 Others
5.2 By Application - United States Mesenchymal Stem Cells Revenue & Forecasts
5.2.1 By Application - United States Mesenchymal Stem Cells Revenue, 2016-2021
5.2.2 By Application - United States Mesenchymal Stem Cells Revenue, 2022-2027
5.2.3 By Application - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
6 Mesenchymal Stem Cells Companies Profiles
6.1 Lonza
6.1.1 Lonza Company Details
6.1.2 Lonza Business Overview
6.1.3 Lonza Mesenchymal Stem Cells Introduction
6.1.4 Lonza Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.1.5 Lonza Recent Developments
6.2 Thermo Fisher
6.2.1 Thermo Fisher Company Details
6.2.2 Thermo Fisher Business Overview
6.2.3 Thermo Fisher Mesenchymal Stem Cells Introduction
6.2.4 Thermo Fisher Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.2.5 Thermo Fisher Recent Developments
6.3 Bio-Techne
6.3.1 Bio-Techne Company Details
6.3.2 Bio-Techne Business Overview
6.3.3 Bio-Techne Mesenchymal Stem Cells Introduction
6.3.4 Bio-Techne Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.3.5 Bio-Techne Recent Developments
6.4 ATCC
6.4.1 ATCC Company Details
6.4.2 ATCC Business Overview
6.4.3 ATCC Mesenchymal Stem Cells Introduction
6.4.4 ATCC Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.4.5 ATCC Recent Developments
6.5 MilliporeSigma
6.5.1 MilliporeSigma Company Details
6.5.2 MilliporeSigma Business Overview
6.5.3 MilliporeSigma Mesenchymal Stem Cells Introduction
6.5.4 MilliporeSigma Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.5.5 MilliporeSigma Recent Developments
6.6 PromoCell GmbH
6.6.1 PromoCell GmbH Company Details
6.6.2 PromoCell GmbH Business Overview
6.6.3 PromoCell GmbH Mesenchymal Stem Cells Introduction
6.6.4 PromoCell GmbH Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.6.5 PromoCell GmbH Recent Developments
6.7 Genlantis
6.7.1 Genlantis Company Details
6.7.2 Genlantis Business Overview
6.7.3 Genlantis Mesenchymal Stem Cells Introduction
6.7.4 Genlantis Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.7.5 Genlantis Recent Developments
6.8 Celprogen
6.8.1 Celprogen Company Details
6.8.2 Celprogen Business Overview
6.8.3 Celprogen Mesenchymal Stem Cells Introduction
6.8.4 Celprogen Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.8.5 Celprogen Recent Developments
6.9 Cell Applications
6.9.1 Cell Applications Company Details
6.9.2 Cell Applications Business Overview
6.9.3 Cell Applications Mesenchymal Stem Cells Introduction
6.9.4 Cell Applications Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.9.5 Cell Applications Recent Developments
6.10 Cyagen Biosciences
6.10.1 Cyagen Biosciences Company Details
6.10.2 Cyagen Biosciences Business Overview
6.10.3 Cyagen Biosciences Mesenchymal Stem Cells Introduction
6.10.4 Cyagen Biosciences Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.10.5 Cyagen Biosciences Recent Developments
6.11 Axol Bioscience
6.11.1 Axol Bioscience Company Details
6.11.2 Axol Bioscience Business Overview
6.11.3 Axol Bioscience Mesenchymal Stem Cells Introduction
6.11.4 Axol Bioscience Mesenchymal Stem Cells Revenue in United States Market (2016-2021)
6.11.5 Axol Bioscience Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Mesenchymal Stem Cells Market Opportunities & Trends in United States Market
Table 2. Mesenchymal Stem Cells Market Drivers in United States Market
Table 3. Mesenchymal Stem Cells Market Restraints in United States Market
Table 4. Key Players of Mesenchymal Stem Cells in United States Market
Table 5. Top Mesenchymal Stem Cells Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Mesenchymal Stem Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Mesenchymal Stem Cells Revenue Share by Companies, 2016-2021
Table 8. Companies Mesenchymal Stem Cells Product Type
Table 9. List of Tier 1 Mesenchymal Stem Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Mesenchymal Stem Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Mesenchymal Stem Cells Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Mesenchymal Stem Cells Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Mesenchymal Stem Cells Revenue (US$, Mn), 2022-2027
Table 17. Lonza Company Details
Table 18. Lonza Business Overview
Table 19. Lonza Mesenchymal Stem Cells Product
Table 20. Lonza Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Lonza Recent Developments
Table 22. Thermo Fisher Company Details
Table 23. Thermo Fisher Business Overview
Table 24. Thermo Fisher Mesenchymal Stem Cells Product
Table 25. Thermo Fisher Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Thermo Fisher Recent Developments
Table 27. Bio-Techne Company Details
Table 28. Bio-Techne Business Overview
Table 29. Bio-Techne Mesenchymal Stem Cells Product
Table 30. Bio-Techne Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Bio-Techne Recent Developments
Table 32. ATCC Company Details
Table 33. ATCC Business Overview
Table 34. ATCC Mesenchymal Stem Cells Product
Table 35. ATCC Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. ATCC Recent Developments
Table 37. MilliporeSigma Company Details
Table 38. MilliporeSigma Business Overview
Table 39. MilliporeSigma Mesenchymal Stem Cells Product
Table 40. MilliporeSigma Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. MilliporeSigma Recent Developments
Table 42. PromoCell GmbH Company Details
Table 43. PromoCell GmbH Business Overview
Table 44. PromoCell GmbH Mesenchymal Stem Cells Product
Table 45. PromoCell GmbH Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. PromoCell GmbH Recent Developments
Table 47. Genlantis Company Details
Table 48. Genlantis Business Overview
Table 49. Genlantis Mesenchymal Stem Cells Product
Table 50. Genlantis Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Genlantis Recent Developments
Table 52. Celprogen Company Details
Table 53. Celprogen Business Overview
Table 54. Celprogen Mesenchymal Stem Cells Product
Table 55. Celprogen Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Celprogen Recent Developments
Table 57. Cell Applications Company Details
Table 58. Cell Applications Business Overview
Table 59. Cell Applications Mesenchymal Stem Cells Product
Table 60. Cell Applications Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Cell Applications Recent Developments
Table 62. Cyagen Biosciences Company Details
Table 63. Cyagen Biosciences Business Overview
Table 64. Cyagen Biosciences Mesenchymal Stem Cells Product
Table 65. Cyagen Biosciences Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Cyagen Biosciences Recent Developments
Table 67. Axol Bioscience Company Details
Table 68. Axol Bioscience Business Overview
Table 69. Axol Bioscience Mesenchymal Stem Cells Product
Table 70. Axol Bioscience Mesenchymal Stem Cells Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Axol Bioscience Recent Developments
List of Figures
Figure 1. Mesenchymal Stem Cells Segment by Type
Figure 2. Mesenchymal Stem Cells Segment by Application
Figure 3. United States Mesenchymal Stem Cells Market Overview: 2020
Figure 4. United States Mesenchymal Stem Cells Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Mesenchymal Stem Cells Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2020
Figure 7. By Type - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
Figure 8. By Application - United States Mesenchymal Stem Cells Revenue Market Share, 2016-2027
Figure 9. Lonza Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Thermo Fisher Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bio-Techne Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. ATCC Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. MilliporeSigma Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. PromoCell GmbH Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Genlantis Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Celprogen Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Cell Applications Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Cyagen Biosciences Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Axol Bioscience Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Animal Stem Cell Therapy Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 89
    Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing The sample to concentrate The stem cells. Finally, The therapy includes transferring The stem cells into The injured site ......
  • Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 104
    According to our LPI (LP Information) latest study, the global Mesenchymal Stem Cells market size was valued at US$ 202.6 million in 2023. With growing demand in downstream market, the Mesenchymal Stem Cells is forecast to a readjusted size of US$ 278.8 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Mesenchymal Stem Cells market. Mesenchymal Stem Cells are expected to show stable growth in the future market. How......
  • Global Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Stem Cells market size was valued at US$ 2693.1 million in 2023. With growing demand in downstream market, the Stem Cells is forecast to a readjusted size of US$ 5700.6 million by 2030 with a CAGR of 11.3% during review period. The research report highlights the growth potential of the global Stem Cells market. Stem Cells are expected to show stable growth in the future market. However, product differentiation, reducing costs......
  • Global Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Stem Cell Therapy market size was valued at US$ 469.1 million in 2023. With growing demand in downstream market, the Stem Cell Therapy is forecast to a readjusted size of US$ 1724 million by 2030 with a CAGR of 20.4% during review period. The research report highlights the growth potential of the global Stem Cell Therapy market. Stem Cell Therapy are expected to show stable growth in the future market. However, product differ......
  • Global Animal Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Animal Stem Cell Therapy market size was valued at US$ 199.3 million in 2023. With growing demand in downstream market, the Animal Stem Cell Therapy is forecast to a readjusted size of US$ 476.2 million by 2030 with a CAGR of 13.2% during review period. The research report highlights the growth potential of the global Animal Stem Cell Therapy market. Animal Stem Cell Therapy are expected to show stable growth in the future ma......
  • Global Stem Cell Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Stem Cell market: According to our latest research, the global Stem Cell market looks promising in the next 5 years. As of 2022, the global Stem Cell market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells. ......
  • Global Animal Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Animal Stem Cell Therapy market size was valued at USD 209.7 million in 2023 and is forecast to a readjusted size of USD 469.9 million by 2030 with a CAGR of 12.2% during review period. Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or di......
  • Global Hematopoietic Stem Cells Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Hematopoietic Stem Cells market: According to our latest research, the global Hematopoietic Stem Cells market looks promising in the next 5 years. As of 2022, the global Hematopoietic Stem Cells market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Adipose Stem Cells (ASCS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Adipose Stem Cells (ASCS) market: According to our latest research, the global Adipose Stem Cells (ASCS) market looks promising in the next 5 years. As of 2022, the global Adipose Stem Cells (ASCS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs